MEDICINOVA, INC. Shareholders' Equity
MEDICINOVA, INC. (MNOV) had Shareholders' Equity of $37.27 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $37.27M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $39.41M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $41.59M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $43.96M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $37.27M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $39.41M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $41.59M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $43.96M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $46.86M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $49.93M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $52.50M 10-Q · filed 2026-08-13 |
| 2024-09-30 | $55.07M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $57.41M 10-Q · filed 2025-11-12 |
| 2024-03-31 | $59.83M 10-Q · filed 2025-11-12 |
| 2023-12-31 | $62.38M 10-K · filed 2026-03-10 |
| 2023-09-30 | $64.67M 10-Q · filed 2024-11-13 |
| 2023-06-30 | $65.18M 10-Q · filed 2024-11-13 |
| 2023-03-31 | $67.73M 10-Q · filed 2024-11-13 |
| 2022-12-31 | $70.24M 10-K · filed 2025-02-19 |
| 2022-09-30 | $73.11M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $76.61M 10-Q · filed 2023-11-09 |
| 2022-03-31 | $80.36M 10-Q · filed 2023-11-09 |
| 2021-12-31 | $83.68M 10-K · filed 2024-02-15 |
| 2021-09-30 | $86.48M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $89.23M 10-Q · filed 2022-11-10 |
| 2021-03-31 | $92.37M 10-Q · filed 2022-11-10 |
| 2020-12-31 | $71.33M 10-K/A · filed 2023-03-28 |
| 2020-09-30 | $73.55M 10-Q · filed 2021-11-12 |
| 2020-06-30 | $71.09M 10-Q · filed 2021-11-12 |
| 2020-03-31 | $73.20M 10-Q · filed 2021-11-12 |
| 2019-12-31 | $74.89M 10-K · filed 2022-02-16 |
| 2019-09-30 | $74.35M 10-Q · filed 2020-10-26 |
| 2019-06-30 | $73.18M 10-Q · filed 2020-10-26 |
| 2019-03-31 | $75.04M 10-Q · filed 2020-10-26 |
| 2018-12-31 | $73.11M 10-K · filed 2021-02-19 |
| 2018-09-30 | $73.55M 10-Q · filed 2019-10-24 |
| 2018-06-30 | $75.59M 10-Q · filed 2019-10-24 |
| 2018-03-31 | $75.57M 10-Q · filed 2019-10-24 |
| 2017-12-31 | $38.64M 10-K · filed 2020-02-13 |
| 2017-09-30 | $34.72M 10-Q · filed 2017-10-23 |
| 2017-06-30 | $33.39M 10-Q · filed 2017-07-26 |
| 2017-03-31 | $32.75M 10-Q · filed 2017-04-26 |
| 2016-12-31 | $34.53M 10-K · filed 2019-02-13 |
| 2016-09-30 | $35.75M 10-Q · filed 2016-10-25 |
| 2016-06-30 | $37.37M 10-Q · filed 2016-07-26 |
| 2016-03-31 | $39.14M 10-Q · filed 2016-04-27 |
| 2015-12-31 | $32.75M 10-K · filed 2019-02-13 |
| 2015-09-30 | $34.63M 10-Q · filed 2015-10-29 |
| 2015-06-30 | $19.95M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $20.95M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $22.01M 10-K · filed 2018-02-13 |
| 2014-09-30 | $22.98M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $24.80M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $26.65M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $25.43M 10-K · filed 2017-02-14 |
| 2013-09-30 | $21.45M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $22.95M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $14.25M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $14.88M 10-K · filed 2015-03-12 |
| 2012-09-30 | $16.70M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $17.87M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $20.58M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $23.50M 10-K · filed 2014-03-27 |
| 2011-09-30 | $19.25M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $22.75M 10-Q · filed 2011-08-15 |
| 2010-12-31 | $24.70M 10-K · filed 2013-03-28 |
| 2009-12-31 | $40.01M 10-K · filed 2013-03-28 |
| 2008-12-31 | $48.04M 10-K · filed 2013-03-28 |
| 2007-12-31 | $66.61M 10-K · filed 2013-03-28 |
| 2006-12-31 | $100.98M 10-K · filed 2013-03-28 |
| 2005-12-31 | $135.71M 10-K · filed 2013-03-28 |
| 2004-12-31 | $7.67M 10-K · filed 2013-03-28 |
| 2003-12-31 | $4.57M 10-K · filed 2013-03-28 |
| 2002-12-31 | $1.12M 10-K · filed 2013-03-28 |
| 2001-12-31 | $8.05M 10-K · filed 2013-03-28 |
| 2000-12-31 | $4.85M 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |